We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Molecular Diagnostic Solution Aids in Early Detection of Hepatitis

By LabMedica International staff writers
Posted on 12 Jun 2023
Print article
Image: Tianlong is helping hospitals in Thailand detect hepatitis early with its molecular diagnostic solution (Photo courtesy of Tianlong)
Image: Tianlong is helping hospitals in Thailand detect hepatitis early with its molecular diagnostic solution (Photo courtesy of Tianlong)

Over 350 million people worldwide are afflicted with viral hepatitis, with 9 out of 10 hepatitis sufferers unaware of their condition. To tackle this issue, Tianlong Science and Technology (Shaanxi, China), an innovative high-tech company specializing in molecular diagnostic products, has joined forces with public hospitals in northern Thailand. The partnership aims to provide detection for hepatitis C (HCV) and hepatitis B (HBV), facilitating early diagnosis and treatment. Tianlong's detection solution for HCV and HBV can aid in curbing the transmission of the diseases through early diagnosis and appropriate treatment.

Since October 2022, public hospitals in Thailand have successfully implemented Tianlong's HCV and HBV detection solution. The reagents developed by Tianlong for HCV and HBV detection, compatible with its PANA9600S nucleic acid extractor and Gentier 96 PCR system, enable rapid testing with high sensitivity, thereby gaining traction among high-end users. Tianlong has established a 7-year agreement with local Thai hospitals, which plan to progressively adopt its HCV and HBV detection solution. This move has paved the way for Tianlong to penetrate the Thai market and allowed it to strengthen its engagement with local high-end users.

Tianlong is determined to widen its footprint in Thailand, closely collaborating with local partners to deliver top-notch solutions and services for its customers. The company also plans to introduce its STIs kits in Thailand shortly, aiming to curb the spread of sexually transmitted infections (STIs). Tianlong anticipates that its molecular diagnostic solutions for hepatitis and other diseases will gain increasing acceptance in the local market, contributing to the health and well-being of the people in Thailand.

"Tianlong can give timely responses both online and offline when we need technical support. We have great confidence in Tianlong's products, and we would welcome more cooperation in the future," said a local hospital representative in Thailand.

Related Links:
Tianlong Science and Technology

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
PSA Test
Humasis PSA Card

Print article

Channels

Clinical Chemistry

view channel
Image: A one-step confirmatory laboratory test could definitively diagnose active syphilis infection within 10 minutes (Photo courtesy of Adobe Stock)

First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes

In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.